Actinium Pharmaceuticals (ATNM)
(Delayed Data from AMEX)
$1.59 USD
-0.06 (-3.64%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.60 +0.01 (0.63%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ATNM 1.59 -0.06(-3.64%)
Will ATNM be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ATNM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ATNM
Is Armata Pharmaceuticals (ARMP) Stock Outpacing Its Medical Peers This Year?
Is Actinium Pharmaceuticals (ATNM) Stock Outpacing Its Medical Peers This Year?
ATNM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Corcept Trumps Q3 Earnings & Sales Estimates, Ups '24 Revenue View
Amarin's Q3 Earnings In Line, Revenues Fall Shy of Estimates
All You Need to Know About Actinium (ATNM) Rating Upgrade to Strong Buy
Other News for ATNM
Is ATNM likely to continue lower? 50 Day Moving Average Resistance shows up after dropping 3.64%
Is ATNM setting up for a drop? 20 Day Moving Average Resistance shows up after gaining 2.48%
ATNM Fell Below 50 Day Moving Average on September 17
ATNM Crossed Above 50 Day Moving Average on September 16
Is ATNM set to breakout? NR7 shows up after dropping 0.61%